Definitive Contract 75N91019C00022
Award Date 9/16/19
Potential Completion Date 8/15/23
Potential Value $1.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Derwood, MD 20855, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Biomarker Strategies LLC for the development of "A Novel Predictive Test for Response to Immunotherapies for Patients with Non-Small Cell Lung Cancer." The contract has a firm fixed price of $223,063.00 and a period of performance from September 19, 2016 to June 18, 2017. As an SBIR Phase I contract, this award aims to support the small business...
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- This $399,951 firm-fixed-price definitive contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the small business Care Progress LLC. The contract supports the development of "BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY" under the NCI's Small Business Innovation Research (SBIR) program, which is a set-aside for small businesses. Care Progress LLC, a for-profit limited liability company, has previously...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled "Non-Invasive Subtyping of Aggressive Tumor and Its Environment" as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC...
- This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
- <p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
- This definitive firm fixed price contract from the Department of Health and Human Services National Institutes of Health National Cancer Institute, with a total small business set aside, is for $299,726.89 to Imago Systems Inc. for the development of a novel diagnostic imaging modality for monitoring tumor responses to a hyperthermia immunotherapy as part of the National Cancer Institute's Moonshot initiative. The award stems from Topic 375 of the NIH/CDC SBIR Contract Solicitation PHS 2018-1,...
- This is a definitive, firm fixed-price contract awarded by the National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, to Hera Testing Laboratories Inc., a for-profit organization. The contract, valued at $293,728.00, is set aside for small businesses. The purpose of the contract is to contribute to studies of cancer health disparities by generating several patient-derived xenograft (PDX) models for non-small cell lung cancer (NSCLC) in an...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a civilian agency, to Cellsight Technologies, Inc., a woman-owned small business. The $1,995,174 contract is for the development of an [18F]F-ARAG imaging agent to quantitatively assess response to immunotherapy in non-small cell lung cancer. This builds on a previous $300,000 SBIR Phase I contract from NCI to evaluate [18F]F-ARAG for predicting response to cancer...